Sequential GO and chemotherapy no benefit for older AML patients according to EORTC/GIMEMA trial
Sequential GO and chemotherapy no benefit for older AML patients according to EORTC/GIMEMA trial
Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential ...